News

2024 Jan 29

Prestigious NIH Grant Explores Repetitive DNA Sequences and Cell Dysfunction

Dr. Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant from the National Institute... Read more

2024 Jan 25

Dr. David Lyden Wins Paget-Ewing Award from Metastasis Research Society

Dr. David Lyden , the Stavros S. Niarchos Professor in Pediatric Cardiology and a professor of pediatrics at Weill Cornell Medicine, has been named the winner of the 2024 Paget-Ewing Award by the Metastasis Research Society... Read more

dopamine neuron senescence after COVID infection

2024 Jan 17

SARS-CoV-2 Can Infect Dopamine Neurons Causing Senescence

A new study reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence—when a cell loses the ability to grow and divide. The researchers from Weill Cornell Medicine... Read more

2024 Jan 16

Dr. Marcus D. Goncalves Inducted into the American Society for Clinical Investigation

Dr. Marcus D. Goncalves , the Ralph L. Nachman, M.D. Research Scholar and an assistant professor of medicine in the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine, has been elected as a member... Read more

2024 Jan 12

NIH Awards Education Grant for Weill Cornell Medicine’s First Post-Baccalaureate Research Program

The National Institute of General Medical Sciences of the National Institutes of Health has awarded Weill Cornell Medicine a $1.8 million five-year grant to fund a new post-baccalaureate research education program that aims... Read more

2024 Jan 12

Stromal Cells May Help Predict Prostate Cancer Metastasis

Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according... Read more

2024 Jan 11

Immunotherapy and Radiation Combo Shows Improved Outcomes for Non-small Cell Lung Cancer

A new study reported that patients with non-small cell lung cancer (NSCLC) treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received... Read more

2024 Jan 03

Weill Cornell Medicine Receives Grant for Blood Test to Diagnose Breast Cancer

Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer. Researchers are... Read more

2023 Dec 29

Awards & Honors: December 2023

Dr. James Bussel , professor emeritus of pediatrics, won the American Society of Hematology’s 2023 Henry M. Stratton Medal for clinical/translational science. The prize honors two senior investigators who have made... Read more

Cells labeled in pink and blue in pancreatic cancer organoid

2023 Dec 26

Scientists Use Organoid Model to Identify Potential New Pancreatic Cancer Treatment

A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according to a new study from researchers at Weill Cornell... Read more

heat map, arcs and tracks representing chromatin rewiring during development

2023 Dec 20

3D Organization of DNA Controls Cell Identity Programs

In the nucleus of cells, long strands of DNA are tightly wrapped around a scaffolding of proteins in a complex called chromatin, like a rolled-up ball of yarn. A new study by Weill Cornell Medicine investigators reveals that... Read more

Drs. Jedd Wolchok and Taha Merghoub in a lab

2023 Dec 13

Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium

San Francisco and New York — Dec. 13, 2023 — The Parker Institute for Cancer Immunotherapy (PICI), the largest concentration of immuno-oncology (IO) expertise in the world, announced it has added Weill Cornell Medicine to... Read more

immunofluorescence image of cells labeled in green, magenta and turquoise

2023 Dec 13

Cholesterol-Lowering Therapy May Hinder Aggressive Type of Colorectal Tumor

Hard-to-detect colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend heavily on the ramped-up production of cholesterol, according to a preclinical study from... Read more

2023 Nov 30

Awards & Honors: November 2023

Dr. John Leonard , senior associate dean for innovation and initiatives, interim chair of the Weill Department of Medicine, and the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, was given the... Read more

2023 Nov 28

Weill Cornell Medicine to Open Medical Research Center at 1334 York Avenue

NEW YORK (Nov. 28, 2023) —Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house, the... Read more

2023 Nov 21

Bishoy M. Faltas Receives Prestigious MERIT Grant

Dr. Bishoy M. Faltas, director of bladder cancer research at the Englander Institute for Precision Medicine at Weill Cornell Medicine, the Gellert Family-John P. Leonard, M.D. Research Scholar and an assistant professor of... Read more

image of cells in bone marrow stained yellow, cyan and red

2023 Nov 14

Researchers Chart the Contents of Human Bone Marrow

A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow. Their findings confirm hypotheses about the anatomy of this tissue and provide a powerful new... Read more

2023 Nov 06

Infographic: Breast Cancer Screening

Detecting breast cancer early is critical. Going in for an annual screening gives you peace of mind knowing that if there is an issue, it gets detected as quickly as possible. Download the guide or review the infographic at... Read more

2023 Nov 03

New Radiopharmaceutical Shows Antitumor Activity in Patients with Advanced Prostate Cancer

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial... Read more

2023 Nov 02

New Strategy Attacks Treatment-Resistant Lymphomas

A surprising mechanism that makes some cancers treatment-resistant has been discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators. The mechanism, which involves the shuttling of messenger RNAs (mRNAs)... Read more